March 01, 2007
Woodcock named to new position at FDA
Janet Woodcock was named to a newly created position as FDA chief medical officer in a management reshuffle that brings in John Dyer to hold her previous titles.
The pharma company manufactures the well-known opioid OxyContin.
FDA Commissioner Dr. Scott Gottlieb has been saying all the right things regarding digital health.
Although if approved, it's not likely to launch in the U.S. for quite some time.